Study Highlights

Exposure to fine particulate matter via air pollution, led to increases in stress hormones and, in a study of healthy college students in China.

Negative effects of pollution exposure decreased after using indoor air purifiers over a 9-day period.

Embargoed until 3 p.m. CT / 4 p.m. ET Monday, Aug. 14, 2017

DALLAS, Aug. 14, 2017 — Exposure to high levels of air pollution increased stress hormone levels and negative metabolic changes in otherwise healthy, young adults in a recent study conducted in China. Air purifiers appeared to lessen the negative effects, according to new research published in the American Heart Association’s journal Circulation.

Researchers focused on fine particulate matter (PM 2.5 ) – a component of air pollution emitted from vehicles, factories, power plants, fires and smoking – because many studies have suggested this type of major air pollutant might lead to cardiovascular and metabolic health consequences, according to Haidong Kan, M.D., Ph.D., study author and professor of environmental health sciences at Fudan University in Shanghai, China.

However, the biological mechanisms linking air pollution to cardiovascular risk are unclear. In this study, the first of its kind, researchers used “metabolomics” – a method that could reflect how glucose, amino acids, fatty acids and lipids are metabolized – to get a snapshot of the chemical processes by which cells produce the substances and energy needed to sustain life.

Researchers recruited 55 healthy, young college students, who received alternate treatments of real and sham air purification in random orders in their dormitory rooms.

Researchers measured indoor and outdoor fine particulate matter levels during the study, and at certain points did health tests and collected blood serum and urine samples to analyze the students’ metabolites, inflammation and oxidative stress biomarkers. They looked for differences in blood serum metabolites, biomarkers and blood pressures with increasing exposure to fine particulate matter.

Researchers found:

Notable changes in 97 blood serum metabolites after fine particulate matter exposure.

An average 82 percent lower level of indoor fine particulate matter with air purifiers versus sham purifiers.

Short-term reductions in stress hormone levels after air purifiers were used.

After 24-hours with real air purifiers in use, exposure levels for fine particulate matter were in the safe range per World Health Organization.

Higher fine particulate matter exposure was also associated with increases in stress hormone levels, which are believed to induce high blood pressure, inflammatory and metabolic effects in the body, Kan said.

Fine particulate matter exposure impacted metabolism of glucose, amino acids, fatty acids and lipids. These changes, along with the significantly higher blood pressure, insulin resistance and biomarkers of inflammation and oxidative stress found among people exposed to higher levels, could be partly responsible for the adverse cardiovascular effects caused by air pollution exposure, researchers said.

“Levels of stress hormones, systolic blood pressure and biomarkers of oxidative stress and inflammation were significantly lower when using real air purifiers,” Kan said. “Although we found significant health benefits with air purifiers, the actual health protection people could get from air purifiers in real living conditions is still not well-determined.”

This was also a small study and whether the results translate to other countries remains to be seen, because air pollution levels are much higher in urban China than in the United States or Europe. Nevertheless, the study highlights air pollution’s potential impact on human health in more ways than we currently know, Kan said.

“Future studies should examine whether the health benefits from short-term air purification can improve long-term health, and whether these findings are also found in people who live in low pollution areas,” Kan said. The current study only focused on one particulate matter size found in pollution.

Co-authors are Huichu Li, M.S.; Jing Cai, Ph.D.; Renjie Chen, Ph.D.; Zhuohui Zhao, Ph.D.; Zhekang Ying, Ph.D.; Lin Wang, Ph.D.; Jianmin Chen, Ph.D.; Ke Hao, Sc.D.; Patrick L. Kinney, Sc.D. and Honglei Chen, M.D. Ph.D. Author disclosures are on the manuscript.

The National Natural Science Foundation of China, Public Welfare Research Program of National Health and Family Planning Commission of China, Shanghai 3-Year Public Health Action Plan, Cyrus Tang Foundation and China Medical Board Collaborating Program funded the study.

Additional Resources:

###

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at www.heart.org/corporatefunding.

About the American Heart Association

The American Heart Association is devoted to saving people from heart disease and stroke – the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies, and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.

For Media Inquiries and AHA/ASA Spokesperson Perspective: 214-706-1173

Karen Astle: 214-706-1392; karen.astle@heart.org

For Public Inquiries: 800-AHA-USA1 (242-8721)

heart.org and strokeassociation.org